2nd Quarter - Termination

DAVIDSON & COMPANY for HEALTH FREEDOM FOUNDATION

Period 2nd Quarter 2008 Filed Jul 14, 2008 Signed by Karen Blitz, Office Manager

Official filing
Firm
DAVIDSON & COMPANY
Client
HEALTH FREEDOM FOUNDATION
Income
$20,000
Expenses
—
Terminated
Jun 30, 2008

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Budget/Appropriations BUD

S. 251 Pharmaceutical Market Access Act of 2007; S. 468 Food and Drug Administration Safety Act of 2007; S. 484 Enhancing Drug Safety and Innovation Act of 2007; H.R. 380 Pharmaceutical Market Access and Drug Safety Act of 2007; H.R. 788 Food and Drug Administration Safety Act of 2007; H.R. 2117 Health Freedom Protection Act of 2007; H.R. 1561 Enhancing Drug Safety and Innovation Act of 2007

LobbyistCovered position, as disclosed
JAMES H DAVIDSON —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 484 (110th), H.R. 1561 (110th), H.R. 380 (110th), S. 251 (110th), S. 468 (110th), H.R. 788 (110th), H.R. 2117 (110th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.